期刊文献+

2011—2012年广东省人类免疫缺陷病毒/获得性免疫缺陷综合征患者的耐药情况分析 被引量:3

In Guangdong Drug Resistance of Patients with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in 2011 and 2012
原文传递
导出
摘要 目的探讨2011—2012年广东省人类免疫缺陷病毒(HIV)/获得性免疫缺陷综合征(AIDS)患者的耐药情况。方法分别收集广东省2011-2012年接受抗病毒治疗满1年以上的患者血浆,检测HIV病毒载量,对病毒载量(VL)>1 000 Copies/ml患者行HIV-1基因分型及耐药位点检测,比较2011—2012年患者的病毒抑制情况、HIV-1基因亚型与感染途径分布、耐药突变的发生情况、治疗药物的耐药情况。结果 2012年治疗失败率明显低于2011年下降,差异有统计学意义(χ2=59.57,P<0.01);通过静脉吸毒、同性和异性性传播的感染患者主要为CRF01_AE亚型,而输血传播感染的患者为CRF01_AE及CRF02_AG亚型;2012年NRT区主要耐药位点M184I/V突变比例明显低于2011年,差异有统计学意义(χ2=6.37,P<0.05);2012年患者3TC、FTC、NVP耐药率均明显低于2011年,差异有统计学意义(χ2=6.97,P<0.05)。结论 2011—2012年广东省HIV/AIDS患者基因亚型以CRF01_AE为主,两年间各类药物主要耐药位点未发生变化;耐药突变是HIV耐药性产生的主要原因,2012年耐药率下降和耐药突变率相符。 Objective To investigate the characteristic of anti-HIV drug resistance of failure treatment HIV/AIDS patients in Guangdong Province in 2011 and 2012.Methods In Guangdong Province the plasma of Patients,who receive antiretroviral treatment for more than one year,were collected in 2012 and 2011.the detection of HIV virus load,the viral load(VL)and 1000cp/ml in patients with HIV-1 genotype and mutation detection.Viral suppression,HIV-1 genotype and distribution of infection,drug resistance,the occurrence of drug resistance of patients in 2012 were compared with 2011,Results In 2012 the failure rate was significantly lower than in 2011,the difference was statistically significant(χ^2=59.57,P〈0.01);Gene subtype of patients infected through intravenous drug use,homosexual and heterosexual transmission is mainly CRF01_AE,and transfusion transmitted infections of patients with CRF01_AE and CRF02_AG subtype;main resistance loci M184I/V of NRT mutation in 2012 was significantly lower than that of in 2011,the difference was statistically significant(χ2=6.37,P0.05);In 2012 resistant rates of 3TC、FTC、NVP were significantly lower than that in 2011,there were statistically significant differences(χ^2=6.97,P0.05).Conclusion In 2011 and 2012 gene subtype of patients with HIV/AIDS is still CRF01_AE subtypes,primarily resistance loci of various types of drugs did not change in Guangdong.Resistance mutations are the main causes of HIV drug resistance,the declined rates of drug resistance were the same as mutation rate in 2012.
出处 《中国药物经济学》 2015年第7期72-74,共3页 China Journal of Pharmaceutical Economics
基金 十二五国家科技重大专项(2012ZX10001003-003)
关键词 人类免疫缺陷病毒 耐药突变 基因型 序列分析 HIV Resistance mutations Genotype Sequence analysis
  • 相关文献

参考文献6

  • 1卓丽,唐小平,陈伟烈,邓西龙.广东省艾滋病患者HIV-1基因亚型分析[J].国际流行病学传染病学杂志,2011,38(1):21-25. 被引量:9
  • 2何浩岚,许飞龙,蔡卫平,陈谐捷,卢葳,何金洋,聂静敏,贾卫东.广东省HIV-1分子流行病学分析[J].广东医学,2012,33(22):3471-3474. 被引量:12
  • 3张旻,尚红,韩晓旭,张子宁,王亚男,刘宝贵,李秀金,刘静,姜拥军,王树祥,张岩,赵斌.中国东北地区未经抗病毒治疗的HIV/AIDS患者HIV毒株的耐药基因变异研究[J].中华微生物学和免疫学杂志,2004,24(11):850-854. 被引量:34
  • 4Bacheler L,Jeffrey S,Hanna G,et a1.Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy[J].J Virol,2001,75(11):4999-5008.
  • 5Byrnes VW,Emini EA,Schleif WA,et al.Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors[J].Antimicrob Agents Chemother,1994,38(6):1404-1407.
  • 6Kozal MJ,Shah N,Shen N,et al.Extensive polymorphisms observed in HIV-1 clade B protease gene high density oligonucleotide arrays[J].Nat Med,1996,2(7):753-759.

二级参考文献32

  • 1刘建芳,严延生,林勋,黄海龙,颜苹苹,陈舸,郑健.福建省HIV-1流行毒株基因分型与流行特征分析[J].中国人兽共患病学报,2006,22(7):601-605. 被引量:21
  • 2万卓越,李杰,刁丽梅,林鹏,邢辉,王玉,马鹏飞,姜树林,邵一鸣.广东省人免疫缺陷病毒1亚型基因序列特征分析[J].中华预防医学杂志,2006,40(5):344-347. 被引量:17
  • 3Thomson MM,Pérez-Alvarez L,Nájera R.Molecular epidemiology of HIV-1 genetic forms and it s significance for vaccine development and therapy.Lancet Infect Dis,2002,2(8):461-471.
  • 4Pillay D,Walker AS,Gibb DM,et al.Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS(PENTA) 5 trial.J Infect Dis,2002,186(5):617-625.
  • 5Atlas A,Granath F,Lindstr(o)m A,et al.Impact of HIV type 1 genetic subtype on the outcome of antiretroviral therapy.AIDS Rcs Hum Retroviruses,2005,21(3):221-227.
  • 6Dealaney S, Zheng N, McQueen P. Emergency of drug-resistant HIV-1 strains from patients on long term ddI therapy. 12th World AIDS Conference. Geneva, 1998, 41: 224.
  • 7Grant RM, Kahn JO, Warmerdam M, et al. Transmission and transmissibility of drug resistant HIV-1. Program and Abstracts of the 9th Conference on Retroviruses and Opportunistic Infections. Seattle, Washington, 2002, 368.
  • 8Durant JCP, Clevenbergh P, Halfon P, et al. Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomized controlled trial. Lancet, 1999, 353: 2195-2199.
  • 9Clevenbergh P, Durant JCP, Halfon P, et al. Persisting long-term benefit of antiretroviral genotypic guided treatment for HIV-infected patients failing on HAART: the VIRADAPT study, week 48 follow up. Antiviral Ther, 1999, 4(Suppl.1): 42.
  • 10Hirsch MS, Conway B, D′Aquila RT, et al. Antiretroviral drug resistance testing in adults with HIV infection. JAMA, 1998, 279: 1984-1991.

共引文献52

同被引文献55

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部